IJK Fact Sheet: iShares S&P Mid-Cap 400 Growth ETF
Share
$105.77
close, Nov 18, 2026
Over the year to Nov 18, 2026, IJK returned +14.6% in total and charged 0.16% a year.
- 1-year total return
- +14.6%
- MDYG +14.5% to Nov 18, 2026
- Expense ratio
- 0.16%
- a year
- Net assets
- $10.1bn
- on Nov 18, 2026
- Net flow, last 5 trading days
- −$10.9m
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
IJK $11,456 +14.6% · MDYG $11,453 +14.5% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−2.5%
3 months−8.8%
Year to date+9.6%
1 year+14.6%
3 years+47.9%
5 years+27.1%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
UNITED THERAPEUTICS1.53%
TECHNIPFMC PLC1.50%
ATI1.45%
TENET HEALTHCARE CORP1.39%
XPO1.33%
ROYAL GOLD1.30%
ITT INC1.13%
WOODWARD1.12%
NVENT ELECTRIC PLC1.08%
TOAST CLASS A1.06%
IJK top ten by weight, 12.9% of the fund, of its 252 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the S&P MidCap 400 Growth Index · First traded Jul 28, 2000 · Benchmark S&P MidCap 400 Growth Index, measured by MDYG, which tracks the same index